CLINICAL TRANSLATION OF BIOENGINEERED TISSUE-BASED THERAPEUTICS (Hall 3F, L3)

Sponsored By 

Concurrent Speaker(s)

• 

  Xin Cheng, PhD

  Shanghai Institute of Biochemistry and Cell Biology, China
• 

  Ryuichi Okamoto, MD, PhD (he/him/his)

  Department of Gastroenterology and Hepatology
  Institute of Science Tokyo, Japan

Presenting Author(s)

• 

  Kevin Costa

  Novoheart, Medera Biopharm, United States
• 

  Shin-Jeong Lee, PhD

  Medicine
  Yonsei University, Republic of Korea
• 

  Marcelo Rivolta, MD PhD

  School of Biosciences
  University of Sheffield and Rinri Therapeutics, United Kingdom
• WZ

  Wei Zuo, PhD (he/him/his)

  School of Medicine
  Tongji University, China

This session will focus on the clinical translation of tissue replacement therapies, including bioengineered 3D tissues, organoids, and organs. We will discuss transplant-based and ex vivo device-based regenerative therapeutics, with applications in endocrine, digestive, urogenital, and neurological fields, as well as the emerging area of xenotransplantation. An ethics expert will also address the regulatory, accessibility, and economic aspects of these advanced therapies.

Presentations:

• CLINICAL APPLICATION OF PATIENT-DERIVED ORGANOIDS IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
  

  Concurrent Speaker: Ryuichi Okamoto, MD, PhD (he/him/his) – Institute of Science Tokyo
• GENE THERAPY CLINICAL TRIAL FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION (MUSIC-HFPEF) INFORMED BY IN VITRO SCREENING WITH STEM CELL-BASED BIOENGINEERED MINI-HEARTS
  

  Presenting Author: Kevin D. Costa – Novoheart, Medera Biopharm
• AUTOLOGOUS TRANSPLANTATION OF AIRWAY BASAL STEM CELLS IN COPD PATIENTS: A RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL
  

  Presenting Author: Wei Zuo, PhD (he/him/his) – Tongji University
• PRECLINICAL STUDY OF HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED ENDOTHELIAL CELLS FOR PERIPHERAL ARTERY DISEASE
  

  Presenting Author: Shin-Jeong Lee, PhD – Yonsei University
• DEVELOPING A PSC-DERIVED THERAPY FOR HEARING LOSS: PAVING THE WAY FOR A FIRST-IN-HUMAN CLINICAL TRIAL
  

  Presenting Author: Marcelo N. Rivolta, MD PhD – University of Sheffield and Rinri Therapeutics
• ENDODERM STEM-CELL DERIVED ISLET TISSUE FOR THERAPEUTICS & DISEASE MODELING
  

  Concurrent Speaker: Xin Cheng, PhD – Shanghai Institute of Biochemistry and Cell Biology